VINCENZO ATELLA CURRICULUM VITAE

VINCENZO ATELLA CURRICULUM VITAE PERSONAL INFORMATION Date of birth: 9 September 1962 Place of birth: Venafro (IS) Citizenship: Italian Home address: Viale dell Umanesimo, 37-00144 Rome Italy Office address: Via Columbia, 2 00133 Rome Italy Phone: +39 06 7259 5606 - Fax: +39 06 2020687 E-mail: atella@uniroma2.it PRESENT ACADEMIC POSITIONS 2001 - present Associate Professor - Permanent position - Department of Economics and Finance (DEF) - University of Roma Tor Vergata. PAST ACADEMIC POSITIONS 1994-2001 Assistant Professor - Permanent position - Department of Financial Economics and Quantitative Studies (SEFEMEQ) - University of Rome Tor Vergata. 1990-1993 Adjunct Professor - Department of Economics - University of Sassari. EDUCATION 1987-1989 Stanford University, Stanford CA. Master of Arts in Economics. 1980-1984 Libera Università Internazionale degli Studi Sociali (Luiss), Rome, Bachelor in Economics (110/110 cum laude). SCHOLARSHIPS, HONORS AND PRIZES Best paper award to the Annual conference on Money, Economy and Management for the paper Household Portfolio Choices, Health Status and National Health Care Systems, a Cross- Country Analysis Based on Share?, Paris, 2010. C.N.R. (National Research Council): 1990 and 1991 scholarship for research activity. Stanford Alumnus, 1989. BANCO DI NAPOLI: Fellowship for Post graduate studies at Stanford University, 1987-1989. CONSORZIO ROMA RICERCHE: Scholarship for post graduate studies, 1987. ISVEIMER: Scholarship for under-graduate studies at LUISS University, 1980-1984. INSTITUTIONAL ACTIVITIES 2012 - present Director of the Centre for Economic and International Studies (CEIS) at the University of Rome Tor Vergata. 2012 - present Co-Director of the Master Erasmus Mundus in International Co-operation and Urban Development. 2011-2012 Member of Academic Senate. 2006 - present Riccardo Faini CEIS Seminars co-organizer at the University of Rome Tor Vergata. 2002 - present Coordinator of the CEIS Working papers series. 1

2002 - present Member of the Doctoral program in Economics and Finance. 2002-2006 Coordinator of the degree in European Economy & Business Law. OTHER APPOINTMENTS: PHD SUPERVISOR Federico Belotti, Lorenzo Carbonari, Francesco D Amico, Silvio Daidone, Giuseppe Ilardi, Joanna Kopinska, Noemi Pace, Andrea Piano Mortari. Founder and Member of the PAA (Public Affair Association). Chief Economist at SIMG (Italian College of General Practitioners). Scientific director at Fondazione Farmafactoring Milan. Adjunct Affiliate at CHP/PCOR (Center for Health Policy), Stanford University. SIVEAS Senior expert at the Ministry of Health, Rome. Member of the Gerson Lehrman Group Council. Member of the CIBB (Centro Interdip. di Biomedica e Biostatistica) Scientific Committee. VISITING PERIODS 2012 CHP-PCOR - Stanford University June-August. 2011 RAND Corporation June-August. 2010 CHP-PCOR - Stanford University June-August. 2009 CHP-PCOR - Stanford University June-August. 2008 CHP-PCOR - Stanford University June-August. 2007 CHP-PCOR - Stanford University June-August. 1998 NBER - Stanford University January-March. RESEARCH INTERESTS TEACHING ACTIVITY Health economics. Poverty, inequality and income distribution. Public finance. Consumption and production theory. Public policy evaluation. PhD Level 2008 - present Applied health Economics, University of Rome Tor Vergata. Master level 2011 - present Health economics for developing countries, Master in Development Economics and International Cooperation (MESCI), University of Rome Tor Vergata. 2008-2011 Public choice, University of Rome Tor Vergata. 2006 - present Social welfare and public choice, Master in Development Economics and International Cooperation (MESCI), University of Rome Tor Vergata. Undergraduate level 2006 - present Macro Economics, University of Rome Tor Vergata. FINANCIAL SUPPORT FOR RESEARCH ACTIVITIES (SELECTED LIST) 2

2012 Ministry of Health, SIVEAS, Department of Programming: Hospital performance indicators. 2010-2011 Ministry of Health, SIVEAS, Department of Programming: Econometric model for public health expenditure and for the definition of standard costs. 2007-2009 PRIN - Ministry of Research, Education and University (MIUR). Welfare, Child cost in collective choice models: cost of rearing, fertility choices and child poverty estimates. Unit coordinator. 2001-2006 Global Healthcare Productivity (GHP) research network - Co-founder of the network and scientific co-ordinator of the Italian unit. 2001-2003 Program ECUITY III, V Framework Program Scientific co-ordinator of the Italian unit. 2001-2003 Program SOE Project MICRESA: Micro-level analysis of the European Social Agenda: combating poverty and social exclusion through changes in social and fiscal policy - Scientific co-ordinator of the unit of the University of Rome Tor Vergata. Three years project financed by the European Commission. 2001-2003 Pharmacia & Upjohn - Complementarità e sostituibilità nella spesa sanitaria pubblica e privata in Italia. Project coordinator. 2001-2002 PRIN - Ministry of Research, Education and University (MIUR). Welfare, Fiscal policies and public choices. Unit coordinator. 1999-2000 European Science Foundation (ESF) Exploratory Research Grant TECH- Europe Research Network. 1998-2003 TECH-Europe - TEchnological Change in Health care global research network - Co-founder and coordinator of the research group at European level. 1998-2001 Program SOE - Project EUROMOD: A tax benefit microsimulation model - Scientific coordinator of the Italian unit. Three years project financed by the European Commission. 1997-1999 BIOMED Programme - Project Patient charge and decision making behaviours of consumers and physicians. Coordinator of the Italian unit. 1997 1998 CNR Health strategic project The determinants of the public-private choices in the Italian healthcare sector. 1995-1997 Human Capital and Mobility (HCM) Program - Project Cost containment policy in the drug sector in Europe. Coordinator of the Italian unit and co-founder of the ENDEP research Network. PROFESSIONAL ACTIVITY 2007-2010 IQWIG (National Agency for Economic Evaluation in the Health Sector), Cologne, Germany - Member of the International Panel of Experts for setting national drug evaluation guidelines. 2006-2010 Centro Europa Ricerche (CER), Rome - Member of the Scientific Committee 2006-2009 Italian National Drugs Agency (AIFA), Rome Member of the Strategic Evaluation Committee. 2004-2006 Prices Observatory, IPI Ministry of Productive Activities, Rome - Economist for the analysis of price trend in Italy. 2003-2006 Istituto Superiore Sanità Drug Observatory (OSMED), Rome Senior advisor and coordinator of the econometric model on public drug expenditure. 3

2003-2005 OSMED, Senior Economist. 2001-2003 Drug Prices Commission CIPE Ministry of Health, Rome - Commission Member, appointed by the Treasury Ministry. 2001-2002 IRI Management, Rome Invited speaker on a series of meetings with managers of the National Institute for Social Security (INPS). 2001 Aspen Institute Italia, scientific coordinator on behalf of Pharmacia Spa of the meeting on Regulation of the health system and drug expenditure. 2000 National Council for the Economy and Labor (CNEL), Rome Scientific Coordinator of the Sixth CNEL Report on Income distribution and redistribution in Italy and Europe - 2000-2001. 1999-2003 Confesercenti (National Association of Retailers and Services Firms), Rome - Economic Advisor to the President Office. 1999-2001 Agency for Regional Health Services (ASSR), Rome - Senior Economist. 1998 National Council for the Economy and Labor (CNEL), Rome - Scientific Coordinator of the Fifth CNEL Report on Income distribution and redistribution in Italy and Europe- 1997-1999. 1998 World Bank - Country Department: East Europe, Washington D.C., USA - Economist for a mission in Belarus for an assessment of the policies on social security, health and income redistribution. 1997 WHO European Region - Member of a task force for development of Health care system in Albania. 1997 Poverty Commission, Rome - Member of a task force for the update of the Italian equivalence scales. 1997-2001 European Commission - DG XII - BIOMED Program, Brussels - Coordinator of the Italian unit in the European Network ENDEP working on Patient charges and decision making behaviors of consumers and physicians. 1996 World Bank - Country Department: North Africa - Economist for a poverty study in Algeria. 1996-1997 European Commission - DG XII - Human Capital and Mobility Program - Brussels - Head of the Italian unit in the European network ENDEP working on "Control on Drug Expenditures in Europe". 1995 World Bank - Country Department: East Europe - Economist for a mission in Belarus for an assessment of the policies on social security, health and income redistribution. COLLABORATIONS WITH PRIVATE ENTERPRISES AND NON-PROFIT FIRMS Abbott, Amgen, ANIA, Assobiomedica, Astra Zeneca, Bristol Mayer Squibb, Confcommercio, Farmafactoring, Farmindustria, Fondazione Masi, Gerson Lehman Group, Merck, NERA, Pfizer Europe, Pfizer Italy, Pharmacia, Schoering Plough. PARTICIPATION TO CONFERENCES AND SEMINARS 2012 OECD, Stanford, AIES Annual Conference, SIE Annual Conference. 2011 University of Sassari, Catholic University, Milan. 2010 Health Economic Seminar Boston University, MIT, Harvard University, University of Brescia, University of Venice. 2009 Ministry of Treasury, Bank of Italy, London School of Economics, Stanford University, Imperial 4

College London. 2007 II Italian Congress of Econometrics and Empirical Economics, VIII International Health Economic Association Conference. 2006 XI AIES Conference, XV European Workshop on Health economics and Econometrics. 2005 European Economic Association, IX World Congress of the Econometric Society, CHILD Annual Meeting, NBER Summer Institute. 2004 STAKES Helsinki. 2003 XII European Workshop on Health economics and Econometrics, IV Conference of the Global Health Productivity Network, Stanford (CA), IV International Health Economic Association Conference, San Francisco (USA). 2002 Chinese Health Economics Institute, Beijing (China), V Meeting AIES, Bologna (Italy), XI European Workshop on Health economics and Econometrics, OECD, International Workshop on Income distribution and welfare, at Bocconi University, Ecuity Project Workshop, International Workshop on Consumption behaviour and welfare measurement, Verona (Italy), II Conference of the Global Health Productivity Network, at Rockfeller Foundation in Bellagio (Italy). 2001 III International Health Economic Association Conference, York (UK). 1999 VIII European Workshop on Health economics and Econometrics, Catania, TECH-MONICA workshop, Rome. 1998 International conference on technological change in health care, Stanford (CA). 1997 SADIBA Conference Bank of Italy. PUBLICATIONS ON INTERNATIONAL REFEREED JOURNALS 2013b Atella V., Belotti F., Daidone S. and G. Ilardi: Stochastic Frontiers and Unobserved heterogeneity: is all that glitters gold?, Stata Journal forthcoming. 2013a Atella V., Fontana L. and D. Kammen: Energy and resource efficiency as a unifying principle for human, environmental and global health, F1000 Research forthcoming. 2012b Atella V., Bhattacharya J. and L. Carbonari: Pharmaceutical industry, drug quality and regulation. Evidence from US and Italy, Health Service Research. February (2012), Vol. 47, Issue 1 pt1, pp. 293 308. 2012a Atella V., Brunetti M. and N. Maestas: Household Portfolio Choices, Health status and Health Care Systems A Cross-Country Analysis Based on SHARE Data, Journal of Banking and Finance, 36 (2012), pp. 1320 1335. 2010b Caro J., Nord E., Siebert U., McGuire A., McGregor M., Henry D., de Pouvourville G., Atella V. and P. Kolominsky-Rabas: IQWiG methods a response to two critiques, Health Economics, October 19, (2010), pp. 1137-1138. 2010a Caro J., Nord E., Siebert U., McGuire A., McGregor M., Henry D., de Pouvourville G., Atella V. and P. Kolominsky-Rabas: The efficiency frontier approach to economic evaluation of health care interventions, Health Economics, October 19, (2010), pp. 1117-1127. 2009 Atella V., Brady A., Catapano A.L., Critchley J., Graham I.M., Hobbs F.D.R., Leal J., Lindgrenh P., Vanuzzo D., Volpe M., Woodk D. and R. Paoletti: Bridging science and health policy in cardiovascular disease: focus on lipid management, Atherosclerosis Supplements, 10 (2009), pp. 3 21. 2008c Atella V., Pace N. and D. Vuri: Are employers discriminating with respect to weight? European Evidence using Quantile Regression, Human Biology and Economics, (2008), Vol. 6, Issue 3, pp. 305-329. 2008b Atella V. and P. Deb: Are primary care physicians, public and private sector specialists substitutes or complements? Evidence from a simultaneous equations model for count data, Journal of Health Economics, (2008), Vol. 27, pp. 770-785. 5

2008a Atella V., Centoni M. and G. Cubadda: Technology shocks, structural breaks and the effects on the business cycle, Economics Letters, (2008), Vol. 100, pp. 392 395. 2006 Atella V., Depalo D., Peracchi F. and C. Rossetti: Drug compliance, co-payment and health outcomes: empirical evidence based on a panel of Italian patients, Health Economics, 15 (2006), pp. 875 892. 2005b Atella V., Hassell K., Schafheutle E. and P. Noyce: Affordability of medicines and patients cost-reducing behaviour. Empirical evidence based on SUR estimates from Italy and in UK, Applied Health Economics and Health Policy, (2005), Vol. 4, No.1, pp. 23-35. 2005a Atella V., Coggins J. and F. Perali: Aversion to inequality in Italy and its determinants, Journal of Economic Inequality, (2005), Vol. 2, No. 2, pp. 117-144. 2004b Atella V. and F. Spandonaro: Private health insurance in Italy: where we stand now, Euro Observer (2004), Vol. 1, pp. 6-7. 2004a Atella V., Brindisi F., Deb P. and F.C. Rosati: The determinants of access to physician services: a latent class Seemingly Unrelated Probit approach, Health Economics, (2004), Vol. 13, Issue 7, pp. 657-668. 2003b Atella V., Atzeni G.F. and P. Belvisi: Investment and exchange rate uncertainty, Journal of Policy Modeling, November (2003),Vol. 25, Issue 8, pp. 811-824. 2003a Atella V., Hassell K., Schafheutle E., Noyce P. and M. Weiss: Cost to the patient or cost to the healthcare system? Which one matters the most for GP prescribing decisions? A UK-Italy comparison, European Journal on Public Health, (2003), Vol. 13, n.1, pp.18-23. 2001b Atella V. and B. Quintieri B: Do R&D spillovers really matter for TFP, Applied Economics, (2001), Vol. 33, n.11, pp. 1385-1389. 2001a Atella V. with TECH Research Network: Technological Change Around The World: Evidence From Heart Attack Care, Health Affairs, (2001), Vol. 20, No.3, pp. 25-42. 2000b Atella V., Brenner G., Haajier-Ruskamp F., Hedvall M.B., Huttin C., Mechtler R. and P. Noyce: 2000a The cost of prescription medicines to patients, Health Policy, (2000), Vol. 52, pp. 129-145. Atella V., Drug cost containment policies in Italy: are they really effective in the long-run? The case of minimum reference price, Health Policy, (2000). Vol. 50, pp. 197-218. 1999 Atella V. and F.C. Rosati: Uncertainty about children s survival and fertility: a test using Indian microdata, Journal of Population Economics, (1999), Vol. 13, pp. 263-278. PUBLICATIONS ON ITALIAN REFEREED JOURNALS 2011 Atella V., Francisci S. and G. Vecchi: La salute degli italiani, 1861-2011, Italian Journal of Health Policy, (2011), Anno 12, n.4, pp. 165-189. 2008 Atella V.: Aderenza e persistenza alla terapia: implicazioni economiche, Giornale Italiano di Farmacoeconomia e Farmacoutilizzazione (2008), Vol.1, No. 3, pp. 5-10. 2007 Atella V. and G. Marini: Is health care expenditure really a luxury good? A reassessment and new evidence based on OECD data, Rivista di Politica Economica, March-April (2007). 2006b Atella V., and F. Belotti: Discussione a Assicurazione sanitaria di F. Barigozzi, Rivista di 2006a Politica Economica, September-October, pp. 257-273. Atella V., Rosati F.C. e M.C. Rossi: Precautionary Saving and Health Risk. Evidence from the Italian households using a time series of cross sections, Rivista di Politica Economica, Maggio-Giugno (2006), pp.115-133. 2004 Atella V., Mennini F.S. and F. Spandonaro: Criteri per l allocazione regionale delle risorse per la sanità: riflessioni sul caso italiano, Politiche Sanitarie, (2004), Vol. 5, n.1, Jenuary- March pp. 27-32. 2002 Atella V. and F.C. Rosati: Spesa, equità e politiche sanitarie in Italia negli anni 90: quali insegnamenti per il futuro, Politica Sanitaria, (2002), Anno 3, n. 1, p.3-17. 2001 Atella V., Caiumi A. and F. Perali: La scelta delle scale di equivalenza e gli effetti sui risultati 6

delle politiche sociali, Economia e Lavoro, (2001), n. 1, pp 59-80. 1998c Atella V. and B. Quintieri: Cambiamento tecnologico e domanda di fattori nell'industria manifatturiera italiana, Rivista di Politica Economica, (1998), Anno LXXXVIII, n. 2, pp.3-42. 1998b Atella V.: Spesa farmaceutica pubblica e controllo dei prezzi: venti anni di problemi ed incomprensioni, MECOSAN, (1998), n. 27, pp.43-52. 1998a Atella V. and B. Quintieri: Productivity growth and the effects of recession, Giornale degli economisti e Annali di Economia, (1998), Vol. 57 n. 3-4, pp.359-386. 1993 Atella V.: Redditività degli investimenti, sviluppo regionale e dualismo economico: problemi di analisi empirica e risultati per il caso italiano nel periodo 1951-1987, Sviluppo Economico, (1993), Vol. 1, n.2, pp.209-238. 1992 Atella V. and G. Pizzo: Scelte ambientali e scelte economiche nella determinazione del livello ottimo di investimenti in protezione dai rumori: un tentativo di riconciliazione, Studi di Economia e Diritto, (1992), n. 2, pp. 271-302. 1991b Atella V. and F. Scacciavillani: I tests sull'ipotesi di efficienza dei mercati delle materie prime, dei cambi e dei titoli a reddito fisso: i Risultati dell'analisi in Time-Domain e le Prospettive dell'analisi in Frequency-Domain, Rivista di Politica Economica, (1991), Anno LXXXI, n.4, pp. 55-102. 1991a Atella V.: La Povertà: i problemi di definizione e di misurazione, Economia e Lavoro, (1991), n. 1, pp. 125-144. 1990 Atella V.: La riduzione della povertà e le prospettive di sviluppo economico nei PVS: una breve riflessione, CEEP Economia, (1990), n. 5, pp. 29-40. PUBLICATIONS ON INTERNATIONAL EDITED BOOKS 2003g 2003f 2003e 2003d 2003c 2003b 2003a Arias C., Atella V., Castagnini R., and F. Perali, Estimation of the sharing rule between adults and children and related equivalence scales within a collective consumption framework, in Household Welfare and Poverty, edited by G. Ferrari and C. Dagum, Physica Verlag Springer. Atella V., Menon M., and F. Perali, Estimation of Unit Values in Cross Sections without Quantity Information and Implications for Demand and Welfare Analysis, in Household Welfare and Poverty, edited by G. Ferrari and C. Dagum, Physica Verlag Springer. Atella V. and TECH Investigator, The relationship between health policies, medical technology trend, and outcomes: A perspective from the TECH Global Research Network, in What is Best and at What Cost: A Disease-Based Approach to Comparing Health Systems, OECD, Paris, France. Atella V., Brenner G., Hedvall M.B., Huttin C., Mechtler R., Noyce P. and E. Schafheutle, Patient survey: International hypertension results, in Patient charges and decision-making behaviors of consumers and physicians, edited by C. Huttin, IOS Press. Atella V., Hedvall M.B., Hoogerbrugge M., Huttin C., Noyce P., Schafheutle and M. Weiss, Results from the conjoint study on physicians, in Patient charges and decision-making behaviors of consumers and physicians, edited by C. Huttin, IOS Press. Atella V., Brenner G., Hedvall M.B., Huttin C., Mechtler R., Noyce P. and E. Schafheutle, Reimbursement systems in ENDEP countries, in Patient charges and decision-making behaviors of consumers and physicians, edited by C. Huttin, IOS Press. Atella V., Physicians prescription behavior and cost to the patients in Italy: first evidence based on Focus Group techniques and prescription data, in Patient charges and decisionmaking behaviors of consumers and physicians, edited by C. Huttin, IOS Press. 1999 Atella V., Giampaoli S., Pilotto L. and D. Vanuzzo, The determinants and consequences of technological change in the health sector: the case of AMI patients in Italy, in Kessler 7

McClellan: A Global Analysis of Technological Change in Health Care: Heart Attacks Kessler - McClellan, The University of Michigan Press. 1995 Atella V. and F.C. Rosati, Productivity Convergence in Sheltered and Unsheltered Sectors: Results form Selected OECD Countries, in Patterns of Trade, Competition and Trade Policies, edited by B. Quintieri, Avebury. 1992 Atella V., On the existence of a price-research-export circuit in the Italian pharmaceutical industry: causality and co-integration of time-series in the 1968-1988 period, in The prescription drug market, edited by Huttin C. and Bosanquet N., North Holland. PUBLICATIONS ON ITALIAN EDITED BOOKS 2012c Atella V., Belotti F., Conti V., Kopinska J. and A. Piano Mortari: I costi delle cure nel Sistema Sanitario italiano: un analisi disaggregata, in Il Sistema Sanitario in controluce Rapporto 2012, edited by Atella V., Franco Angeli, Milan. 2012b Atella V. and F. Cincotti: La spesa sanitaria e i vincoli di finanza pubblica, in Il Sistema Sanitario in controluce Rapporto 2012, edited by Atella V., Franco Angeli, Milan. 2012a Atella V., Kopinska J., Belotti F. and A. Piano Mortari: I costi dell obesità in Italia, in VII Rapporto annuale Health Search 2011/2012, Rixpress, Florence. 2011f Atella V.: Spesa sanitaria e sostenibilità finanziaria: quale futuro?, in La sanità in Italia. Organizzazione, governo, regolazione, mercato, edited by C. De Vincenti, R. Finocchi Ghersi and A. Tardiola, Il Mulino, Bologna. 2011e Atella V., Francisci S. and G. Vecchi: Salute, in In ricchezza e in povertà, edited by G. Vecchi, Il Mulino, Bologna. 2011d Atella V., Belotti F. and A. Piano Mortari: I costi delle cure nel Sistema Sanitario italiano: un analisi disaggregata, in Il Sistema Sanitario in controluce Rapporto 2011, edited by Fondazione Farmafactoring, Franco Angeli, Milan. 2011c Atella V. and F. Cincotti: La spesa sanitaria e i vincoli di finanza pubblica, in Il Sistema Sanitario in controluce Rapporto 2011, edited by Fondazione Farmafactoring, Franco Angeli, Milan. 2011b Atella V. and F. Cincotti : La spesa sanitaria e i vincoli di finanza pubblica, in Il Sistema Sanitario in controluce Rapporto 2010, edited by Fondazione Farmafactoring, Franco Angeli, Milan. 2011a Atella V. and G. Nunziante: Gli effetti micro e macro della spesa sanitaria sulla crescita economica, in Il Sistema Sanitario in controluce Rapporto 2010, edited by Fondazione Farmafactoring, Franco Angeli, Milan. 2010b Atella V., Cincotti F. and S. Daidone: Spesa sanitaria pubblica ed effetti sulle famiglie, in Il Sistema Sanitario in controluce Rapporto 2009, edited by Fondazione Farmafactoring, Franco Angeli, Milan. 2010a Atella V., Cincotti F. and S. Daidone: Vincoli di finanza pubblica e deficit sanitari regionali, in Il Sistema Sanitario in controluce Rapporto 2009, edited by Fondazione Farmafactoring, Franco Angeli, Milan. 2009b Atella V. and F. Cincotti: La spesa sanitaria ed il quadro macroeconomico, in La Sanità in controluce, edited by Fondazione Farmafactoring, Franco Angeli, Milan. 2009a Atella V. and F. Belotti: La spesa sanitaria privata in Italia: le evidenze empiriche, in La sanità in Italia, edited by A. Pedone, Il Sole24ore, Rome. 2008b Atella V., Carbonari L. and F. Cincotti: Spesa sanitaria e deficit: un analisi a livello regionale, in La sanità in Italia, edited by A. Pedone, Il Sole24ore, Rome. 2008a Atella V. and F. Cincotti: Vincoli di Finanza pubblica, deficit regionali e inefficienze: le sfide del SSN, in Sanità e Finanza: una cultura in crescita, edited by Fondazione Farmafactoring, 8

Franco Angeli, Milan. 2006 Atella V.: «Buche» di keynesiana memoria, in Mediterraneo del Nord. Un altra idea di Mezzogiorno, edited by N. Rossi, Laterza, Bari. 2003b Atella V., Bernardi B. and M.C. Rossi: Le previsioni di spesa sanitaria a livello nazionale e regionale: i risultati del modello econometrico del CEIS Tor Vergata, in Primo Rapporto sulla Sanità in Italia, edited by Atella V., Donia-Sofio A., Mennini F.S. and F. Spandonaro, 2003a Gruppo Italpromo Editore, Rome. Atella V., Bernardi B. and M.C Rossi: La spesa sanitaria privata e gli effetti redistributivi delle politiche sanitarie in Italia, in Primo Rapporto sulla Sanità in Italia, edited by Atella V., Donia-Sofio A., Mennini F. and F. Spandonaro, Gruppo Italpromo Editore, Rome. 2001 Atella V., Atzeni G.F. and P. Belvisi: Verso un cambio forte: quali effetti sugli investimenti delle imprese italiane?, in Le imprese esportatrici italiane, edited by Beniamino Quintieri, Il Mulino, Bologna. 2000e 2000d 2000c 2000b 2000a Atella V. and ENDEP Research Network: Il costo della salute in Europa: dove i pazienti sono più protetti?, in Le politiche sociali in Italia ed in Europa. Coerenza e convergenza delle azioni - V Rapporto CNEL sulla distribuzione e redistribuzione del reddito, edited by V. Atella, CNEL, Roma. Atella V., Berliri C. and V. Parisi: Gli effetti redistributivi della politica economica e sociale, in Le politiche sociali in Italia ed in Europa. Coerenza e convergenza delle azioni - V Rapporto CNEL sulla distribuzione e redistribuzione del reddito, edited by V. Atella, CNEL, Rome. Atella V. and V. Parisi: Retribuzioni, costo del lavoro e distribuzione del reddito in Italia, in Le politiche sociali in Italia ed in Europa. Coerenza e convergenza delle azioni - V Rapporto CNEL sulla distribuzione e redistribuzione del reddito, edited by V. Atella, CNEL, Rome. Atella V. and V. Parisi: La convergenza delle politiche sociali nell area dell EURO, in Le politiche sociali in Italia ed in Europa. Coerenza e convergenza delle azioni - V Rapporto CNEL sulla distribuzione e redistribuzione del reddito, edited by V. Atella, CNEL, Rome. Atella V. and V. Parisi: Il quadro macroeconomico e le politiche economiche, in Le politiche sociali in Italia ed in Europa. Coerenza e convergenza delle azioni - V Rapporto, CNEL sulla distribuzione e redistribuzione del reddito, edited by V. Atella, CNEL, Rome. 1998 Atella V., Perali F. and N. Rossi:, Riforma del welfare e giustizia sociale: il ruolo delle scale di equivalenza in Lo stato sociale in Italia: quadrare il cerchio edited by L. Paganetto, Il Mulino, Bologna. 1997c 1997b 1997a Atella V., Caiumi A. and F. Perali: Scale di equivalenza e misurazione della povertà in Italia, Modelli per la politica economica - Banca d Italia SADIBA. Atella V. and P. Roberti: Il contenimento della spesa farmaceutica: l impatto sulle imprese, in Il lavoro, l Europa e la sovranità sociale - IV rapporto CNEL sulla distribuzione e redistribuzione del reddito in Italia (1996-1997), edited by N. Rossi, Il Mulino, Bologna. Atella V. and P. Roberti: Il contenimento della spesa farmaceutica: l impatto sulle famiglie, in Il lavoro, l Europa e la sovranità sociale - IV rapporto CNEL sulla distribuzione e redistribuzione del reddito in Italia (1996-1997), edited by N. Rossi, Il Mulino, Bologna. 1995 Atella V.: Il quadro macroeconomico e la distribuzione del reddito (Macroeconomic scenario and Income distribution), in Competizione e Giustizia Sociale. Terzo rapporto CNEL su distribuzione e redistribuzione del reddito, edited by N. Rossi, Il Mulino, Bologna. 1991 Atella V. and F. Scacciavillani: Shocks e persistenza nel mercato dei titoli di stato: evidenze empiriche per gli USA, Contributi all'analisi economica, in Ricerche e metodi per la politica economica, Banca d Italia. 9

BOOKS 2001 Atella V. and B Quintieri: Domanda dei fattori, progresso tecnologico e politiche fiscali nell industria manifatturiera italiana negli anni 70 ed 80, Il Mulino, Bologna. EDITED BOOKS 2012 Atella V.: Il Sistema Sanitario in controluce Rapporto 2012, Franco Angeli, Milan. 2005 Atella V., Donia-Sofio A., Mennini F., and F. Spandonaro: III Rapporto CEIS Sanità 2005: Sette parole chiave del SSN, Gruppo Italpromo Editore, Rome. 2004 Atella V., Donia-Sofio A., Mennini F., and F. Spandonaro: II Rapporto CEIS Sanità 2004: Sostenibilità, equità e ricerca dell efficienza, Gruppo Italpromo Editore, Rome. 2003 Atella V., Donia-Sofio A., Mennini F., and F. Spandonaro: I Rapporto sulla Sanità in Italia, Gruppo Italpromo Editore, Rome. 2002 Atella V.: VI Rapporto CNEL sulla distribuzione e ridistribuzione del reddito in Europa, CNEL, Rome. 2000 Atella V.: Le politiche sociali in Italia ed in Europa. Coerenza e convergenza delle azioni - V Rapporto CNEL sulla distribuzione e ridistribuzione del reddito in Italia ed in Europa, CNEL, Roma. WORKING PAPERS 2013b Atella V. and V. Conti, The effect of age and time to death on health care expenditures: the Italian experience, CEIS Working Paper n. 267. 2013a Atella V., and L. Carbonari: When Elders Rule: Is Gerontocracy Harmful for Growth?, CEIS Working Paper n. 263. 2012c Atella V. and J. Kopinska: Criterio di ripartizione e simulazione a medio e lungo termine della spesa sanitaria in Italia: una proposta operativa, mimeo. 2012b Atella V. and J. Kopinska: The determinants of drug compliance: evidence based on a quantile regression approach, CEIS Working Paper n. 247. 2012a Atella V., Belotti F., Daidone S. and G. Ilardi: Stochastic frontiers analysis using Stata, CEIS Working Paper n. 251. 2011c Atella V., Belotti F., Daidone S., Ilardi G., and G. Marini: Cost-containment policies and hospital efficiency: evidence from a panel of Italian hospitals. CEIS Working Paper n. 228. 2011b Atella V. and J. Kopinska: Body weight of Italians: the weight of Education, CEIS Working Paper n. 189. 2010b Atella V., Belotti F. and D. Depalo: Disentangling true determinants of drug therapy effectiveness: A double fixed effects approach, CEIS Working Paper n. 186. 2010a Atella V. and F. D Amico: Who is responsible for your health: You, your doctor or new technologies?, CEIS Working Paper n.167. 2008 Atella V. and M.C. Rossi: Does child labour positively affects the probability to access health care services by children?, mimeo. OTHER PUBLICATIONS AND NEWSPAPER ARTICLES 2012d La spesa sanitaria in tempi di spending review: il quadro di sintesi dei prossimi anni, Quaderni della Fondazione Farmafactoring, n.2. 10

2012c l futuro del sistema sanitario nazionale tra sfide da vincere e inefficienze da eliminare, Quaderni della Fondazione Farmafactoring, n.1. 2012b Dieta di Stato. Un altro punto di vista, (http://www.chicago-blog.it/2012/09/07/dieta-di-stato-un-altro-punto-di-vista-di-vincenzoatella/). 2012a Alcune riflessioni sulle recenti proposte di controllo della spesa sanitaria, (http://www.chicago-blog.it/2012/06/19/alcune-riflessioni-sulle-recenti-proposte-di-controllodella-spesa-sanitaria-di-vincenzo-atellazo-atella/). 2010b Health as an engine of economic growth, (http://www.healtheurope.org/index.php?option=com_content&task=view&id=179&itemid=0). 2010a La sanità e i farmaci in Italia: le anomalie, i problemi, le possibili soluzioni, Fondazione FareFuturo with L. Carbonari, (http://www.farefuturofondazione.it/documenti/pdf/studio_ceis_tor _Vergata%5B1%5D.pdf). 2008e Ma esiste davvero l effetto Baumol in sanità?, Care, n.3, p.17. 2008d I farmaci come strumento per il controllo della spesa sanitaria, Il Cerino, November 26 (http://www.centroeuroparicerche.it/cerino.asp?idn=105). 2008c Aderenza e persistenza alla terapia: implicazioni economiche, Giornale Italiano di Farmacoeconomia e Farmacoutilizzazione 1(3):5-10. 2008b Dal 2010 oltre tre miliardi di euro l anno di risparmi dalla prevenzione cardiovascolare con interventi adeguati sul colesterolo, Supplemento Affari e Finanza di Repubblica, (http://www.simg.it/documenti/comunicati/2008_statine_affari-e-finanza_web.jpg). 2008a Concorrenza ed efficienza nei modelli sanitari regionali, with G. Tria, Paradoxa, ANNO II - Numero 4 - Ottobre/Dicembre. 2007 Una cura per I deficit della sanità, with L. Carbonari and C. Pollastri, (http://www.lavoce.info/articoli/pagina2805.html). 2007 Gli sconti non sono uguali per tutti, with F. Belotti, (http://www.lavoce.info/articoli/pagina1000089.html). 2006 Famiglie, potere d acquisto e concorrenza, (http://www.lavoce.info/articoli/pagina2282.html). 2004b Le mani vuote. Una società con più costi e meno sussidi, with N. Rossi, Il Mulino, 2, March- 2004a April. Un debole settore farmaceutico, Italiani-Europei, n.4, (http://www.italianieuropei.it/it/ie-online/itemlist/user/536-vincenzoatella.html). 2002 Il federalismo fiscale, with F. Scacciavillani, (http://www.lavoce.info/articoli/pagina102.html). 1998 Riccometro e povertà familiare: strumento efficace?, with A. Caiumi and F. Perali, La Famiglia, 32, November-December, 1998, n. 192. 1997 Quale politica per il sistema farmaceutico italiano? CEIS Newsletter, Anno 3, n.2-3, pp.6-10. 1996 Quanto costa curarsi in Europa? CEIS Newsletter, Anno 2, n.6, pp.4-7. WORK IN PROGRESS Atella V., A. Holly, L. Gardiol and J. Huguenin: Asymmetric information in health care services utilization in Italy and Switzerland: the role of private insurance. Atella V., Angrisani M. and M. Brunetti: Household Portfolio Choices, Insurance generosity and Health status: evidence from US. Atella V., Bhattacharya J. and G. Vecchi: The effect of new technologies on life expectancy: the case of antibiotics in Italy. Atella V., G. Marini and G. Trovato: Cost containment policies and hospital outcomes. 11

Atella V. and P. Deb: Health outcomes of internal migrants in Italy. Atella V., Belotti F., Depalo D. and A. Piano Mortari: Measuring spatial effects in presence of institutional constraints: the case of Italian Local Health Authority expenditure. Atella V., Belotti F., Depalo D. and A. Piano Mortari: A Toolkit to Reconcile GMM and FIML Estimators in Spatial Models. Atella V., Belotti F. and F. D Amico: Can better drug treatment improve long-run financial sustainability of NHS in Italy? The case of Statins. REFEREE ACTIVITY Aging Clinical and Experimental Research, Applied Economics, Demography, Disease Management & Health Outcomes, Economics and Human Biology, European Health Economics, Giornale degli Economisti, Health Economics, Journal of Applied Econometrics, Journal of Banking and Finance, Journal of Health Economics, Journal of Population Economics, Journal of Royal Statistical Society, Labour, Pharmacoeconomics, Politica Sanitaria, Ricerche Economiche, Rivista Internazionale di Scienze Economiche e Commerciali, Rivista Italiana degli Economisti, Rivista di Politica Economica, Statistical Methods and Applications, Social Science and Medicine, Statistics in Medicine, Value in Health. 12